by Sergi | Dec 15, 2025 | Press Releases
Amira Therapeutics’ Lead Compound AMI463 Demonstrates 60% Tumor Reduction in Preclinical Oral Study AMI463 has been tested in a murine model showing a tumor reduction of 60% compared with the control group. Amira is currently preparing a meeting with the AEMPS to...
by Sergi | Apr 9, 2024 | Press Releases
Amira Therapeutics Receives Orphan Drug Designation for AMI463 in Soft Tissue Sarcoma in the United States Amira therapeutics has received orphan drug designation (ODD) for its compound AMI463 by the FDA. The compound had previously received the designation of rare...
by Sergi | May 11, 2023 | AMI463, Scientific Papers
By Jun-ichi Sakamaki and Noboru Mizushima Cell Structure and Function, 2023, Volume 48, Issue 1, Pages 99-112, Released on J-STAGE May 11, 2023, Advance online publication April 06, 2023, Online ISSN 1347-3700, Print ISSN 0386-7196, https://doi.org/10.1247/csf.23016...
by Sergi | Jan 24, 2023 | AMI463, Scientific Papers
by Patricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, Gabriela Guillén, Gabriel Gallo-Oller, Guillem Pons, Julia Sansa-Girona, Miguel F. Segura, Josep Sánchez de Toledo, Lucas Moreno, Soledad Gallego, and Josep Roma Cancers 2023, 15(3),...
by Sergi | Jun 22, 2022 | AMI605, Scientific Papers
By Mengyi Lao, Xiaozhen Zhang, Hanshen Yang, Xueli Bai, and Tingbo Liang Molecular Medicine volume 28, Article number: 69 (2022) DOI: https://doi.org/10.1186/s10020-022-00492-7 Abstract Cancer is the leading cause of mortality worldwide. Regulator of calcineurin...
